Cargando…
Celastrol attenuates arterial and valvular calcification via inhibiting BMP2/Smad1/5 signalling
Vascular calcification is an important risk factor for the mortality and morbidity in chronic kidney disease (CKD). Unfortunately, until now there is no certain medication targeting vascular calcification in CKD. In this study, we explored the inhibitory effect of celastrol on high calcium–induced v...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686965/ https://www.ncbi.nlm.nih.gov/pubmed/32954678 http://dx.doi.org/10.1111/jcmm.15779 |